Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

BANK OF IR NC PREF STOCK: 16% BEARISH SLUMP IN 5 SESSIONS

Loading stream...

(VIANEWS) - Investors were disappointed with Bank of Ireland's recent financial performance, leading its shares to fall 16.01% over five sessions from EUR24.05 to EUR20.20. This decline occurred as part of a wider market decline; ISEQ All Share index dropped 1.37% to EUR8,385.91 as investors assessed their investment strategies. Now this market has witnessed two consecutive sessions of losses as investors review their strategies for investing.

More news about BANK OF IR NC PREF (DD7E.IR).

Categories

stockMarket

Tags

DD7E.IRStock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockBANK OF IR NC PREF
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com